-
1
-
-
79959260091
-
Empirical development of improved diagnostic criteria for neurofibromatosis 2
-
Baser ME, Friedman JM, Joe H, Shenton A, Wallace AJ, Ramsden RT, Evans DG (2011) Empirical development of improved diagnostic criteria for neurofibromatosis 2. Genet Med 13:576-81
-
(2011)
Genet Med
, vol.13
, pp. 576-581
-
-
Baser, M.E.1
Friedman, J.M.2
Joe, H.3
Shenton, A.4
Wallace, A.J.5
Ramsden, R.T.6
Evans, D.G.7
-
2
-
-
21044447532
-
Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: A study of 24 patients
-
15776319 10.1055/s-2005-837581 1:STN:280:DC%2BD2M7ktlKktA%3D%3D
-
Ruggieri M, Iannetti P, Polizzi A, La Mantia I, Spalice A, Giliberto O, Platania N, Gabriele AL, Albanese V, Pavone L (2005) Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics 36:21-34
-
(2005)
Neuropediatrics
, vol.36
, pp. 21-34
-
-
Ruggieri, M.1
Iannetti, P.2
Polizzi, A.3
La Mantia, I.4
Spalice, A.5
Giliberto, O.6
Platania, N.7
Gabriele, A.L.8
Albanese, V.9
Pavone, L.10
-
3
-
-
0026746684
-
A clinical study of type 2 neurofibromatosis
-
1484939 1:STN:280:DyaK3s7jsVSjug%3D%3D
-
Evans DG, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992) A clinical study of type 2 neurofibromatosis. Q J Med 84:603-618
-
(1992)
Q J Med
, vol.84
, pp. 603-618
-
-
Evans, D.G.1
Huson, S.M.2
Donnai, D.3
Neary, W.4
Blair, V.5
Newton, V.6
Harris, R.7
-
4
-
-
0027302828
-
Neurofibromatosis type 2 in the pediatric age
-
8355853 10.1227/00006123-199307000-00014 1:STN:280:DyaK3szmtFaitQ%3D%3D
-
Mautner VE, Tatagiba M, Guthoff R, Samili M, Pulst SM (1993) Neurofibromatosis type 2 in the pediatric age. Neurosurgery 33:92-96
-
(1993)
Neurosurgery
, vol.33
, pp. 92-96
-
-
Mautner, V.E.1
Tatagiba, M.2
Guthoff, R.3
Samili, M.4
Pulst, S.M.5
-
5
-
-
0032421712
-
The diagnosis and management of neurofibromatosis type 2 in childhood
-
9874852 10.1016/S1071-9091(98)80003-X 1:STN:280:DyaK1M%2Fpt1Sisw%3D%3D
-
MacCollin M, Mautner VE (1998) The diagnosis and management of neurofibromatosis type 2 in childhood. Semin Pediatr Neurol 5:243-252
-
(1998)
Semin Pediatr Neurol
, vol.5
, pp. 243-252
-
-
Maccollin, M.1
Mautner, V.E.2
-
6
-
-
0032730964
-
Pediatric presentation of type 2 neurofibromatosis
-
10569966 10.1136/adc.81.6.496 1:STN:280:DC%2BD3c%2FjvFymsA%3D%3D
-
Evans DG, Birch JM, Ramsden RT (1999) Pediatric presentation of type 2 neurofibromatosis. Arch Dis Child 81:496-499
-
(1999)
Arch Dis Child
, vol.81
, pp. 496-499
-
-
Evans, D.G.1
Birch, J.M.2
Ramsden, R.T.3
-
7
-
-
33644574352
-
Clinical presentations of neurofibromatosis type 2 in childhood
-
Ruggieri M, Huson SM (1999) Clinical presentations of neurofibromatosis type 2 in childhood. Eur J Pediatr Neurol 3:66
-
(1999)
Eur J Pediatr Neurol
, vol.3
, pp. 66
-
-
Ruggieri, M.1
Huson, S.M.2
-
8
-
-
0242708725
-
Neurofibromatosis type 2 in the pediatric population
-
10.1177/08830738030180101301
-
Nunes F, MacCollin M (2002) Neurofibromatosis type 2 in the pediatric population. J Child Neurol 18:718-724
-
(2002)
J Child Neurol
, vol.18
, pp. 718-724
-
-
Nunes, F.1
Maccollin, M.2
-
9
-
-
33644686430
-
Central nervous system meningiomas in the first two decades of life: A clinicopathological analysis of 87 patients
-
16383246
-
Rushing EJ, Olsen C, Mena H, Rueda ME, Lee YS, Keating RF, Packer RJ, Santi M (2005) Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients. J Neurosurg 103(Suppl):489-495
-
(2005)
J Neurosurg
, vol.103
, Issue.SUPPL.
, pp. 489-495
-
-
Rushing, E.J.1
Olsen, C.2
Mena, H.3
Rueda, M.E.4
Lee, Y.S.5
Keating, R.F.6
Packer, R.J.7
Santi, M.8
-
10
-
-
33744822484
-
Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2
-
16765675 10.1016/j.ajo.2005.12.042
-
Bosch MM, Boltshauser E, Harpes P, Landau K (2006) Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2. Am J Ophthalmol 141:1068-1077
-
(2006)
Am J Ophthalmol
, vol.141
, pp. 1068-1077
-
-
Bosch, M.M.1
Boltshauser, E.2
Harpes, P.3
Landau, K.4
-
11
-
-
72949122116
-
Neurofibromatosis type 2 (NF2). Study of 7 patients
-
19921555 1:STN:280:DC%2BD1MjmvVKquw%3D%3D
-
Pascual-Castroviejo I, Pascual-Pascual SI, Viaño J (2009) Neurofibromatosis type 2 (NF2). Study of 7 patients. Neurologia 24:457-461
-
(2009)
Neurologia
, vol.24
, pp. 457-461
-
-
Pascual-Castroviejo, I.1
Pascual-Pascual, S.I.2
Viaño, J.3
-
12
-
-
0035849530
-
The clinical and diagnostic implications of mosaicism in the neurofibromatosis
-
11409413 10.1212/WNL.56.11.1433 1:STN:280:DC%2BD3Mzks1KisA%3D%3D
-
Ruggieri M, Huson S (2001) The clinical and diagnostic implications of mosaicism in the neurofibromatosis. Neurology 56:1433-1443
-
(2001)
Neurology
, vol.56
, pp. 1433-1443
-
-
Ruggieri, M.1
Huson, S.2
-
15
-
-
84861191703
-
Ohtahara syndrome with emphasis on recent genetic discovery
-
Pavone P, Spalice A, Polizzi A, Parisi P, Ruggieri M (2012) Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 34:459-468
-
(2012)
Brain Dev
, vol.34
, pp. 459-468
-
-
Pavone, P.1
Spalice, A.2
Polizzi, A.3
Parisi, P.4
Ruggieri, M.5
-
16
-
-
58049188823
-
Neurofibromatosis type 1 and infantile spasms
-
Ruggieri M, Iannetti P, Clementi M, Polizzi A, Incorpora G, Spalice A, Pavone P, Praticò AD, Elia M, Gabriele AL, Tenconi R, Pavone L (2009)Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 25:211-6
-
(2009)
Childs Nerv Syst
, vol.25
, pp. 211-216
-
-
Ruggieri, M.I.1
-
17
-
-
67651173054
-
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2
-
19587327 10.1056/NEJMoa0902579 1:CAS:528:DC%2BD1MXovFCrsLY%3D
-
Plotkin SR, Stemmer-Rachamimov AO, Barker FG 2nd, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E (2009) Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 361:358-367
-
(2009)
N Engl J Med
, vol.361
, pp. 358-367
-
-
Plotkin, S.R.1
Stemmer-Rachamimov, A.O.2
Barker II, F.G.3
Halpin, C.4
Padera, T.P.5
Tyrrell, A.6
Sorensen, A.G.7
Jain, R.K.8
Di Tomaso, E.9
-
18
-
-
75749140889
-
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
-
20150363 10.1093/neuonc/nop010
-
Mautner VF, Nguyen R, Kutta H, Fuensterer C, Bokemeyer C, Hagel C, Friedrich RE, Panse J (2010) Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 12:14-18
-
(2010)
Neuro Oncol
, vol.12
, pp. 14-18
-
-
Mautner, V.F.1
Nguyen, R.2
Kutta, H.3
Fuensterer, C.4
Bokemeyer, C.5
Hagel, C.6
Friedrich, R.E.7
Panse, J.8
-
19
-
-
84863950588
-
Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: A retrospective review of 31 patients
-
22805104 10.1097/MAO.0b013e31825e73f5
-
Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd (2012) Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients. Otol Neurotol 33:1046-5
-
(2012)
Otol Neurotol
, vol.33
, pp. 1046-1055
-
-
Plotkin, S.R.1
Merker, V.L.2
Halpin, C.3
Jennings, D.4
McKenna, M.J.5
Harris, G.J.6
Barker II, F.G.7
|